Translational Research: Target Identification
One of the first steps in discovering a new therapeutic is identifying a specific molecular target or phenotypic readout for which there is sufficient evidence that it plays a key role in disease progression or symptomology. This may involve approaches utilizing transgenic animals, monitoring signal transduction networks in ex vivo human samples, or genetic studies.
Target AssayScreeningHits and
HitHit to LeadLead Series
NIDDK-Specific Funding Opportunities
- PAR-17-270, NIDDK Central Repositories Non-renewable Sample Access (X01)
- See NIDDK Current Funding Opportunities or the NIH Guide for Grants and Contracts for more information on active funding opportunities to support basic research on disease biology
- PAR-16-034, Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01)